Journal article
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
Authors
Ray KK; Colhoun HM; Szarek M; Baccara-Dinet M; Bhatt DL; Bittner VA; Budaj AJ; Diaz R; Goodman SG; Hanotin C
Journal
The Lancet Diabetes & Endocrinology, Vol. 7, No. 8, pp. 618–628
Publisher
Elsevier
Publication Date
August 1, 2019
DOI
10.1016/s2213-8587(19)30158-5
ISSN
2213-8587